Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

New Feature: All Finviz Members Now Get Real-Time Earnings Data

Merus N.V.

Contributing Author

Recent Articles by Merus N.V.

Oct-24	Merus' Interim Data on Petosemtamab in Metastatic Colorectal Cancer Demonstrates Monotherapy Activity and Robust Response Rate in Combination with FOLFOX/FOLFIRI with Well Tolerated Safety GlobeNewswire
Oct-14	Merus Announces Publication of an Abstract on Petosemtamab in Metastatic Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics GlobeNewswire
Oct-13	Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics GlobeNewswire
Aug-28	Merus to Present at the 2025 Wells Fargo Healthcare Conference GlobeNewswire
Aug-06	Merus to Present at the Canaccord Genuity 45th Annual Growth Conference GlobeNewswire
Aug-05	Merus Announces Financial Results for the Second Quarter 2025 and Provides Business Update GlobeNewswire
Aug-04	Merus N.V. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Jun-04	Merus N.V. Announces Pricing of Public Offering of Common Shares GlobeNewswire
Jun-03	Merus N.V. Announces Proposed Public Offering of Common Shares GlobeNewswire
May-27	Merus to Present at Upcoming Investor Conferences GlobeNewswire
May-22	Merus' Petosemtamab with Pembrolizumab Interim Data Demonstrates Robust Efficacy and Durability in 1L PD-L1+ r/m HNSCC GlobeNewswire
May-15	Merus Announces the Journal Publication of Petosemtamab Mechanism of Action GlobeNewswire
May-08	Merus to Present at BofA Securities 2025 Health Care Conference GlobeNewswire
May-07	Merus Announces Financial Results for the First Quarter 2025 and Provides Business Update GlobeNewswire

Affiliate • Advertise • API and Exports • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)